Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BAY 61-3606 |
| Synonyms | |
| Therapy Description |
BAY 61-3606 is a small molecule inhibitor of Spleen Tyrosine Kinase (SYK), which may suppress cell growth (PMID: 22237022, PMID: 30347478). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BAY 61-3606 | BAY-613606 | SYK Inhibitor 15 | BAY 61-3606 is a small molecule inhibitor of Spleen Tyrosine Kinase (SYK), which may suppress cell growth (PMID: 22237022, PMID: 30347478). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| RB1 inact mut | retinoblastoma | sensitive | BAY 61-3606 | Preclinical | Actionable | In a preclinical study, a retinoblastoma cell line was sensitive to BAY 61-3606 in cell culture and in xenograft models, demonstrating increased apoptosis (PMID: 22237022). | 22237022 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|